Clinicopathologic and immunohistochemical correlation in sporadic pancreatic endocrine tumors: possible roles of utrophin and cyclin D1 in malignant progression

Human Pathology

Volumn 38, Issue 5, 2007, Pages 732-740

  Chang, Martin C ^a   Xiao, Sheng ^a   Nosé, Vânia ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cyclin D1; Endocrine tumors; Immunohistochemistry; Pancreas; Utrophin

Indexed keywords

CYCLIN D1; CYTOSKELETON PROTEIN; KI 67 ANTIGEN; UTROPHIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOCRINE TUMOR; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS FUNCTION; PANCREAS TUMOR; PROTEIN EXPRESSION; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN D1; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UTROPHIN;

EID: 34147168213     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.10.019     Document Type: Article

References (17)

1. In: DeLellis R.A., Lloyd R., Heitz P.U., and Eng C. (Eds). Pathology and genetics of tumors of endocrine organs (2004), IARC Press, Lyon 177-182
2. Mertens F., Johansson B., Hoglund M., and Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 57 (1997) 2765-2780
3. Lemeta S., Salmenkivi K., Pylkkänen L., et al. Frequent loss of heterozygosity at 6q in pheochromocytoma. Hum Pathol 37 (2006) 749-754
4. Speel E.J.M., Richter J., Moch H., et al. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol 155 (1999) 1787-1794
5. Rigaud G., Missiaglia E., Moore P.S., et al. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 61 (2001) 285-292
6. Barghorn A., Speel E.J.M., Farspour B., et al. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am J Pathol 158 (2001) 1903-1911
7. Nguyen T.M., Helliwell T.R., Simmons C., et al. Full-length and short isoforms of utrophin, the dystrophin-related protein. FEBS Lett 358 (1995) 262-266
8. Sewry C.A., Nowak K.J., Ehmsen J.T., and Davies K.E. A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours. Neuromuscul Disord 15 (2005) 779-785
9. Motokura T., Bloom T., Kim H.G., et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350 (1991) 512-515
10. Chung D.C., Brown S.B., Graeme-Cook F., et al. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab (2000) 4373-4378
11. Guo S.S., Wu X., Shimoide A.T., Wong J., Moatamed F., and Sawicki M.P. Frequent overexpression of cyclin D1 in sporadic pancreatic endocrine tumours. J Endocrinol 179 (2003) 73-79
12. Kushner J.A., Ciemerych M.A., Sicinska W., et al. Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth. Mol Cell Biol 25 (2005) 3752-3762
13. Nguyen T.M., Ellis J.M., Love D.R., et al. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 115 (1991) 1695-1700
14. Warnakulasuriya K.A., and Johnson N.W. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 21 (1992) 404-408
15. Hall P.A., and McCluggage W.G. Assessing p53 in clinical contexts: unlearned lessons and new perspectives. J Pathol 208 (2006) 1-6
16. Deshpande V., Fernandez-del Castillo C., Muzikansky A., et al. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 28 (2004) 1145-1153
17. Deschamps L., Handra-Luca A., O'Toole D., et al. CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survival. Hum Pathol 37 (2006) 802-808